| Particulars |
| Company Name |
Natco Pharma Ltd |
| Face Value |
2 |
| BSE Code |
524816 |
| Year End |
202603 |
| Full Year |
| Equity (Rs . Cr) |
39.23 |
| B.V. (Rs) |
501.20 |
| Sales (Rs . Cr) |
3,594.60 |
| NP (Rs . Cr) |
1,299.73 |
| NP Var% |
-26.00 |
| Div% |
250.00 |
| CPS (Rs) |
75.90 |
| EPS (Rs) |
66.30 |
| Traded Value(Rs . Lakhs) |
234.43 |
| 52 Week High |
1,216.00 |
| 52 Week Low |
786.00 |
| Price BSE |
822.00 |
| Price NSE |
821.00 |
| Market Capital(Rs . Cr) |
16,120.10 |
| P/C Ratio |
10.80 |
| P/E Ratio |
12.40 |
| Price Vs.BV |
1.64 |
| Latest Quarter |
| Year End |
202606 |
| Sales (Rs . Cr) |
596.60 |
| NP (Rs . Cr) |
74.60 |
| NP Var % |
-84.00 |
| Trailing Twelve Months |
| Year End |
202606 |
| Sales |
4,119.60 |
| OPM |
54.49 |
| NP |
1,838.50 |
| NP Var% |
-46.85 |
| EPS |
45.47 |
| PE |
18.07 |
|